Good volume so far. Well overdue this run. Still at ridiculous prices. Buying at this level shouldn't be a problem. Way oversold.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025